Wang, J., & Gaida, M. (2016). Endothelial nitric oxide synthase traffic inducer (NOSTRIN) is a negative regulator of disease aggressiveness in pancreatic cancer. Clinical cancer research, 22(24), . https://doi.org/10.1158/1078-0432.CCR-16-0511
Chicago-Zitierstil (17. Ausg.)Wang, Jian, und Matthias Gaida. "Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) Is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer." Clinical Cancer Research 22, no. 24 (2016). https://doi.org/10.1158/1078-0432.CCR-16-0511.
MLA-Zitierstil (9. Ausg.)Wang, Jian, und Matthias Gaida. "Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) Is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer." Clinical Cancer Research, vol. 22, no. 24, 2016, https://doi.org/10.1158/1078-0432.CCR-16-0511.